Literature DB >> 1525586

Thyroid nodules in pregnancy.

J I Hamburger1.   

Abstract

Thyroid nodules are common in pregnant women. Most of them are benign. Toxic autonomous nodules may be seen infrequently, and the diagnosis is supported by elevated free thyroid hormone levels and undetectable levels of TSH. The most common and most important problem is the diagnosis of thyroid cancer. FNB is the most reliable diagnostic tool. FNB findings also can be used to indicate the urgency for surgery and the appropriate extent of the operation when surgery is indicated. Best use of FNB data requires that the cytopathologist provide tissue diagnoses and that there has been enough experience to permit reasonable inferences of cancer probability for each diagnosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525586     DOI: 10.1089/thy.1992.2.165

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  3 in total

1.  Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice.

Authors:  E Papini; R Negro; A Pinchera; R Guglielmi; A Baroli; P Beck-Peccoz; P Garofalo; M P Pisoni; M Zini; R Elisei; L Chiovato
Journal:  J Endocrinol Invest       Date:  2010-07-13       Impact factor: 4.256

2.  Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Authors:  Alex Stagnaro-Green; Marcos Abalovich; Erik Alexander; Fereidoun Azizi; Jorge Mestman; Roberto Negro; Angelita Nixon; Elizabeth N Pearce; Offie P Soldin; Scott Sullivan; Wilmar Wiersinga
Journal:  Thyroid       Date:  2011-07-25       Impact factor: 6.568

Review 3.  Thyroid nodules and cancer during pregnancy, post-partum and preconception planning: Addressing the uncertainties and challenges.

Authors:  Maria Papaleontiou; Megan R Haymart
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-11-22       Impact factor: 4.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.